Table 1

Titers of PR3-ANCA and MPO-ANCA in serum from WG patients, polyarteritis nodosa patients, and aortitis syndrome patients used in this study.

No. (sample code) (bleeding date)

PR3-ANCA (U/ml)

MPO-ANCA (U/ml)

1. (Q9-40) (5/9/1996)

29.2

< 1.3

(R9-10) (9/27/1996)

19.1

< 1.3

(S9-31) (11/21/1996)

10.7

< 1.3

2. (R9-7) (9/27/1996)

3.8

< 1.3

(S9-29) (11/19/1996)

3.5

< 1.3

3. (S9-32) (11/21/1996)

18.8

< 1.3

4. (D10-41) (4/4/2000)

14.0

< 1.3

5. (M10-24) (2/3/2004)

< 1.3

< 1.3

6. (M10-28) (2/3/2004)

< 1.3

< 1.3

7. (G10-37) (5/15/2002)

< 1.3

< 1.3

8. (H10-51) (9/2/2002)

< 1.3

< 1.3

Uehara et al. Diagnostic Pathology 2009 4:23   doi:10.1186/1746-1596-4-23